CECILY HANNA: Open Payments
NPI 1578104261 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,576 in 14 payments from 11 companies in 2025. Trend: 2023 $379 · 2024 $1,335 · 2025 $1,576
Food & beverage: $1,576
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $286 |
| Boston Scientific Corporation | 2 | $262 |
| ABBVIE INC. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| ACADIA Pharmaceuticals Inc | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $121 |
| KYOWA KIRIN, INC. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Amarin Pharma, Inc. | 1 | $113 |
Products named: AMS 700, VRAYLAR, Auvelity, DAYBUE, VOQUEZNA, CRYSVITA, FARXIGA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
